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Background: Intrachromosomal segmental duplications provide the substrate for non-allelic homologous recombination,
facilitating extensive copy number variation in the human genome. Many multi-copy gene families are embedded within
genomic regions with high levels of sequence identity (>95%) and therefore pose considerable analytical challenges. In
some cases, the complexity involved in analyzing such regions is largely underestimated. Rapid, cost effective analysis
of multi-copy gene regions have typically implemented quantitative approaches, however quantitative data are not an
absolute means of certainty. Therefore any technique prone to degrees of measurement error can produce ambiguous
results that may lead to spurious associations with complex disease.
Results: In this study we have focused on testing the accuracy and reproducibility of quantitative analysis techniques.
With reference to the C-C Chemokine Ligand-3-like-1 (CCL3L1) gene, we performed analysis using real-time Quantitative
PCR (QPCR), Multiplex Ligation-dependent Probe Amplification (MLPA) and Paralogue Ratio Test (PRT). After controlling
for potential outside variables on assay performance, including DNA concentration, quality, preparation and storage
conditions, we find that real-time QPCR produces data that does not cluster tightly around copy number integer values,
with variation substantially greater than that of the MLPA or PRT systems. We find that the method of rounding
real-time QPCR measurements can potentially lead to mis-scoring of copy number genotypes and suggest caution
should be exercised in interpreting QPCR data.
Conclusions: We conclude that real-time QPCR is inherently prone to measurement error, even under conditions
that would seem favorable for association studies. Our results indicate that potential variability in the physicochemical
properties of the DNA samples cannot solely explain the poor performance exhibited by the real-time QPCR systems.
We recommend that more robust approaches such as PRT or MLPA should be used to genotype multi-allelic copy
number variation in disease association studies and suggest several approaches which can be implemented to ensure
the quality of the copy number typing using quantitative methods.
Keywords: Copy number variation, Multi-allelic, CCL3L1, Real-time quantitative PCR, Multiplex ligation-dependent probe
amplification, Paralogue ratio testBackground
Structurally complex regions of the human genome contain
a wealth of information that is yet to be fully understood
within the context of evolution and disease. Here we use
the term “complex” to describe genomic regions containing
highly duplicated sequence of >95% sequence identity (eg.* Correspondence: stuart.cantsilieris@monash.edu
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article, unless otherwise stated.segmental duplications) demonstrating a range of diploid
copies (>3 copy number classes). The C-C Chemokine
Ligand-3-like-1 (CCL3L1) gene is one such example [1].
The quantitative methods commonly used to genotype
multi-allelic copy number polymorphisms (CNPs) are not
absolute, therefore accuracy and reproducibly are required
to generate robust disease associations [2]. Single or multi
locus genotyping methods including Multiplex Ligation-
dependent Probe Amplification (MLPA), Paralogue Ratio
Test (PRT) and real-time Quantitative PCR (QPCR) are
flexible, and cost effective ways to analyze multi-allelictral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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these techniques can provide an accurate assessment
across a range of diploid copy numbers, their reproduci-
bility can be influenced by a number of factors including
assay design, sample quality and operator error.
A challenging aspect of multi-allelic copy number ana-
lysis is that the relative difference between copy number
classes becomes smaller and more difficult to discriminate
as copy number increases [4]. Despite this challenge,
CNP analysis should produce data that clusters tightly
around integer values [5], unless there is evidence for
tissue mosaicism in which different cell types contain
different copy numbers [6]. As such, tissue mosaicism
can occur over a continuous spectrum (1-99%), and can
result in extensive overlap between integer classes
resulting in data that seemingly indicates a continuous
copy number distribution. However, similar data can also
be produced when measurements of non-mosaic tissues
are imprecise and unable to discriminate CNVs with a
high level of accuracy, potentially leading to erroneous
conclusions.
Indeed, differences in these observations made in a
number of studies support the conclusion that such
measurement error can complicate data interpretation
[7] and these effects are clearly evident in studies of the
CCL3L1 gene and disease susceptibility [1,8,9]. In some
cases, there could be misconceptions surrounding assay
validation and/or data interpretation, and if this is coupled
with a lack of transparency regarding the distribution
of raw unrounded copy number measurements, it may
lead to spurious results that are difficult to explain. The
CCL3L1 gene represents a particularly intriguing locus
for study, most notably for its implication in HIV AIDS
susceptibility [1], but also because this region demon-
strates several layers of complexity. In addition to being
copy number variable, this locus is highly population
stratified and the presence of extreme levels of sequence
duplication can complicate assay design. As such due to
the presence of the CC3L3 pseudogene, the analysis of
certain CCL3L1 sequences differs with respect to copy
number content and should be considered when attempt-
ing to compare methods and studies.
In this study we aim to demonstrate some simple
approaches for assessing the quality of genotyping data
when using methods such as real-time QPCR, PRT and
MLPA for the analysis of multi-allelic copy number. These
methods are evaluated by examining the copy number




We selected 150 DNA samples from patients of European
origin. Genomic DNA was isolated from venous bloodleukocytes using a phenol/chloroform extraction proced-
ure as previously described [10]. The concentration and
purity of the DNA samples was determined using the
NanoDrop Specrophotometer (Thermo Scientific). We
considered the genomic DNA samples to be free of
contaminants or solvents if the 260/280 ratio resulted in a
range between 1.7-2.1 and the 260/230 ratio was >1.5.
The samples were collected as part of ongoing eye studies
at the Royal Victorian Eye and Ear Hospital (RVEEH),
Melbourne. Subjects were given a standard risk factor
questionnaire and following clinical examination are
considered healthy control individuals. The study was
conducted in accordance with the Declaration of Helsinki
and according to the National Health and Medical Research
Council of Australia’s statement on ethical conduct in
research involving humans, revised in 2000. Written
informed consent was obtained from all individuals,
and ethics approval for the project was provided by the
Human Research and Ethics Committee of the Royal
Victorian Eye and Ear Hospital (RVEEH), Melbourne.
Multiplex Ligation-dependent Probe Amplification (MLPA)
Two colour MLPA was conducted as previously described
[11]. We designed probes targeting exon 1 and exon 3 of
the CCL3L1 gene listed in Table 1 and these were was
normalized against two reference probes known to have
a diploid copy number state of two unless there is an
obvious phenotype. The reference probes targeted the
CREBBP and EP300 genes located on chromosome 16
and 22 respectively (Table 1). The reagents for the MLPA
reaction were purchased from Fisher Biotec (Australia).
Briefly, 150–250 ng of DNA in a final volume of 5 μl was
denatured at 98°C for 5 minutes. After cooling to room
temperature, 1.5 μl of probe mix containing CCL3L1
MLPA probes and two additional reference loci, was
combined with 1.5 μl of Hybridization buffer and added
to the sample, heat denatured at 95°C for 1 minute
followed by hybridization at 60°C for 16 hours. Ligation
was performed at 54°C by adding 32 μl of ligation reaction,
and after 15 minutes the enzyme was inactivated by heating
at 95°C for 5 minutes. Polymerase Chain Reaction (PCR)
amplification was carried out under the following con-
ditions: 1 cycle of 98°C for 1 minute; 35 cycles of 95°C
30 seconds, 57°C 30 seconds, 72°C 30 seconds; and
1 cycle of 72°C 20 minutes. The PCR reaction was per-
formed in 25 μl. From each PCR reaction, 1 μl was mixed
with 8.9 μl of HiDi formamide and 0.1 μl of ROX500 size
standard (Applied Biosystems). Product separation was
performed on the ABI 3130 Electrophoresis 16 capillary
sequencer (Applied Biosystems). Data Analysis was per-
formed as previously described [12] using the GeneMap-
per Software (Applied Biosystems) and the peak heights
were exported to Microsoft Excel. Each peak height was
normalized against the sum of two control loci to generate
Table 1 MLPA probe sequences used for targeting the CCL3L1 gene and two reference loci EP300 and CREBBP
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median of all ratios for the corresponding peak. These
values were ordered from low to high and subgroups
corresponding to different DNA copy numbers were
calculated to determine the relative differences between
the subgroups.
Real-time quantitative PCR (QPCR)
Real-time Quantitative PCR was performed according to
the TaqMan® Copy Number Assays protocol (Applied
Biosystems). We used 20 ng/μL of genomic DNA in a
10 μL reaction, consisting of 5 μL of 2× TaqMan® Geno-
typing Master Mix, 0.5 μL of RNaseP TaqMan assay
20× working stock, 0.625 μL of CCL3L1 Forward 10 μM,
0.625 μL of CCL3L1 Reverse 10 μM, 0.3 μL of CCL3L1
MGB probe 10 μM and 1 μL DH2O. The CCL3L1 MGB
probe sequence is as follows MGB-6FA: TTCGAGGCC
CAGCGACCTCA. The PCR primer sequences are as
follows CCL3L1 Forward: GGGTCCAGAAATACGTCAGT
and CCL3L1 Reverse: CATGTTCCCAAGGCTCAG as
previously described [13]. Reactions were performed in
duplicate, the cycling times were 1 cycle of 95°C for
10 minutes, and 40 cycles of 95°C for 15 seconds and
60°C for 1 minute. To assess the PCR efficiencies of the
test and reference locus, we performed a series of 10-fold
serial dilutions for both the CCL3L1 and RNaseP PCR
reactions. We found that the PCR efficiencies were
approximately equal, differing by less than 1%. We
exported the CT values for both and analyzed them
using CopyCaller™ software from Applied Biosystems.
CopyCaller™ performs a comparative CT (ΔΔCT) relative
quantitation analysis whereby the difference between
the threshold cycles of the target and reference gene is
calculated, the ΔCT of the test sample is compared to a
calibrator of known copy number. We chose the calibrator
sample which represented two copies of the CCL3L1 gene
as tested by MLPA.
Paralogue Ratio Test (PRT)
We performed Single Plex Paralogue Ratio Test (PRT)
using the method described previously [5]. We used
20 ng/μL of genomic DNA in a 25 μL reaction, comprising
of 5 μL of 5× Bioline My Taq Buffer, 2 μL of 10 pmol/μLCCL3C Forward: GGC TAA GAC CCC TTC TAG AG
and CCL3C Reverse: AAT CAT GCA GGT CTC CAC T
Primer, 1 μL Dimethyl sulfoxide (DMSO), 0.25 μL Bioline
My Taq Polymerase and 14.75 μL DH2O. The cycling times
were 1 cycle of 95°C for 1 minute, 24 cycles of 95°C for
30 seconds, 55°C for 30 seconds and 70°C for 1 minute,
followed by 1 cycle of 70°C for 40 minutes. The PCR
primers were FAM labeled and for each PCR reaction, 1 μl
was mixed with 8.9 μl of HiDi Formamide and 0.1 μl of
ROX500 size standard (Applied Biosystems). PCR product
separation was performed on the ABI 3130 Electrophoresis
16 capillary sequencer (Applied Biosystems). Data Analysis
was performed using the GeneMapper Software (Applied
Biosystems) and the peak heights were exported to Micro-
soft Excel. Copy number was calculated as the ratio of the
CCL3L1 peak height against the reference peak height of
the diploid CCL3 gene.Results
Assay design
The CCL3L1 gene is approximately 1.9 kb in size and
resides in a 90 kb segmental duplication on chromo-
some 17q12 (Figure 1). CCL3L1 contains 3 exons and
shares >95% sequence identity with the CCL3 gene. As
exons 2 and 3 are duplicated in the CCL3L pseudogene,
a quantitative assay targeting exons 2 or 3 will in some
instances, produce 1–2 copies more in comparison to an
assay targeting exon 1. The PRT assay previously described
by Carpenter et al. was specifically designed to avoid target-
ing the CCL3L pseudogene, an approach to only amplify
the active gene in disease association studies [5]. In con-
trast, many studies (reviewed in [7]) using real-time QPCR,
have targeted exon 3 also co-amplifying the CCL3L pseudo-
gene. The real-time QPCR primers used in this study, have
been described previously and target exon 3 [13]. In order
to allow a direct comparison between these systems,
we leveraged the multiplexing capability of MLPA, and
designed two probes targeting exons 1 and 3 of the
CCL3L1 gene (Figure 1). As the real-time QPCR assay
targets exon 3 and the PRT assay targets exon 1, we could
then compare both techniques to the two individual probe
results generated by the MLPA assay.
Figure 1 Schematic representation of the CCL3L1 gene located on chromosome 17q12. Overlapping segmental duplications are indicated
by the black and grey arrows and the probe and primer positions for the PRT, real-time QPCR and MLPA assays are indicated by labels.
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In order to validate each of the three genotyping meth-
odologies, we compared 12 samples previously identified
as having 1, 2, 3 or 4 CCL3L1 copies (three samples of
each copy number class) using the MLPA assay, and
compared these with results generated by both the PRT
and real-time QPCR systems. We found that the geno-
type calls between all three methodologies were highly
concordant, demonstrating that each assay represented
data specific to each exon.
Assessment of assay performance and separation of
integer copy number
We genotyped 150 genomic DNA samples using three
quantitative assays MLPA, PRT and real-time QPCR. We
plotted the raw unrounded copy number estimates on a
histogram for all samples to provide an overall assessment
on the quality of the data (Figures 2 and 3). Both the PRT
and MLPA exon 1 systems demonstrated clear grouping
of measures, consistent with integer clustering (Figure 2A
and B). Clearly distinguishable from the histogram are 4
distinct clusters, each surrounding a normalized ratio
of 0, 0.5, 1.5, and 2 consistent with 0, 1, 2, 3 and 4 diploid
CCL3L1 copies. A direct comparison of copy number
genotypes demonstrated 97% (145/150) concordance
of copy number calls between the two assays with theFigure 2 The distribution of unrounded CCL3L1 copy number measur
assays. A. The MLPA assay demonstrates clear clustering, with peaks cente
from 0–4 copies. B. The PRT assay demonstrates a distribution of 0–5 copieexception of five samples within the three to five copy
number range differing by only single copy (Figure 4A).
Using a concordance plot to examine the degree of
correlation between the MLPA and PRT systems, we
demonstrated an R2 value of 0.91. The high degree of
clustering exhibited by the histogram plots of raw
unrounded copy number and the high degree of cor-
relation and clustering shown in the concordance plot
leaves little doubt as to the assignment of integer copy
number (Figure 4A). We next examined the performance
of real-time QPCR, with respect to cluster quality and
assignment of integer copy number by comparison to
data obtained by MLPA in the same 150 DNA samples.
As the real-time QPCR and MLPA exon 3 assays amplify
the CCL3L pseudogene, the range and frequency of inte-
ger copy number extends from 0–6 copies, with a higher
frequency of 4 and 5 copy genotypes than would be
expected if only exon 1 was amplified. Contrary to the
data we observed with the MLPA system, the real-time
QPCR assay performed quite poorly over a large sample
range (Figure 3A). We found that overall, real-time QPCR
produced a continuous spread of copy number values
rather than discrete clusters (Figure 3A). Interestingly,
real-time QPCR appeared to demonstrate a far more
consistent clustering around 1 and 2 copy number classes,
compared to reliably clustering the difference between 2,ements plotted on a histogram from the PRT and MLPA exon 1
red on integer values and gaps between each of the clusters ranging
s, with peaks clearly centered on integer values.
Figure 3 The distributions of unrounded CCL3L1 copy number measurements plotted on a histogram from real-time QPCR and MLPA
exon 3 assays. A. The real-time QPCR assay demonstrates substantial variation around integer values. Without defined gaps between each of
the clusters, assignment of whole copy number is performed by rounding the data to the nearest integer. B. The MLPA assay demonstrates a
distribution of 0–6 copies with peaks centered on integer values. Copy number assignment can be performed by the groups of samples to a
particular cluster.
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adequately infer copy number genotype based on the
clustering of unrounded measures, the 2-ΔΔCT values
for the real-time QPCR assay were rounded to the
nearest copy number integer. We achieved 81% (121/
150) concordance with genotypes obtained with MLPA,
with the highest discrepancies present in the 3 from 4
copy range (Table 2). Interestingly, when we performed
the concordance plot between the two assays, the R2
between the two assays was higher than expected
(R2 0.87), yet the overall cluster quality was quite poor
(Figure 4B), suggesting that real-time QPCR has a rea-
sonable level of accuracy but exhibits poor precision.
Discussion
Measurement error has the power to drastically influence
disease association studies, and this is particularly evident
when performing analysis of multi-allelic CNPs. Studies
have shown that even a small degree of differential bias,Figure 4 Comparison of the raw ratio data between MLPA, PRT and r
measurements clearly demonstrates grouping around integer values and excell
a difference between PRT and MLPA of a single copy, however clustering both
assigned. B. A comparison between MLPA and real-time QPCR demonstrates
vertical spread of measurements on the concordance plot demonstrates a po
The correlation between real-time QPCR and MLPA is high (R2 0.87), suggestinapplied systematically to large case/control data sets, is
likely to result in spurious association between multi-allelic
CNPs and disease [2,5] Our results demonstrate quite con-
clusively that real-time QPCR is prone to measurement
error and performs poorly when applied to the CCL3L1
multi-allelic CNP region, when compared to alternative
techniques such as MLPA or PRT.
The performance of real-time QPCR has previously
been assessed for genotyping multi-allelic CNP regions
such as the CCL3L1 gene [14] and the Beta-defensin gene
cluster [2,15,16]. In each case, two main conclusions
concerning the results have been reported 1. There is a
lack of clear integer clustering 2. There are discrepancies
between some copy number calls when compared to alter-
native approaches. Both of these findings are supported by
the data presented here. Previous studies have attempted
to compare the performance of CCL3L1 genotyping using
the real-time QPCR and PRT systems [14]. However as
the assays targeted different exons, the presence of aeal-time QPCR using concordance plots. A. MLPA and PRT based
ent correlation, as indicated by the R2 value of 0.91. Five samples represent
PRT and MLPA measurements allows copy number to be unambiguously
a greater degree of variation between the two measurements. An almost
or degree of clustering in the 3–6 copy range between the two assays.
g a low level of precision with respect to QPCR.
Table 2 CNV genotyping calls from three independent
techniques, QPCR, PRT and MLPA, when analyzing the
CCL3L1 gene
CCL3L1 exon 1 CCL3L1 exon 3
C# PRT MLPA MLPA QPCR
0 copies 9 9 9 9
1 copy 25 25 24 26
2 copies 67 67 50 53
3 copies 39 43 22 28
4 copies 9 6 35 25
5 copies 1 0 6 7
6 copies 4 2
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techniques. Additionally, the cases and controls used in
the study by Field et al. were extracted using different
techniques potentially introducing variation in template
quality as a contributor to the poor performance of real-
time QPCR.
Several studies have suggested that the biological prop-
erties of the DNA including protein content, shearing,
methods of extraction and storage conditions are potential
contributors to the poor performance of real-time QPCR
for analyzing multi-allelic CNPs [2,14,15,17]. Additionally,
it has been suggested that real-time QPCR will perform
comparably to PRT if the concentration of DNA samples
is normalized to a uniform concentration, and the effi-
ciency between the test and reference loci differ by less
than 5% [18]. With knowledge of these potential variables
on assay performance, we felt that it would be unfair to
perform a method comparison on DNA samples that were
subject to such limitations. Therefore, we reasoned that if
DNA quality is crucial to the success of real-time QPCR,
then using high quality input DNA samples of similar
concentration, generated using a single technique, and
stored under uniform conditions, should produce high
quality data. However, the results we present here do
not support the conclusion that sample quality or PCR
efficiency are the only reason for the variability observed
with the real-time QPCR system, and thus we present an
alternative hypothesis.
A question that has not been expressly raised when
conducting disease association studies using real-time
QPCR has been; what is the required number of technical
replicates to generate reproducible data using an appro-
priate standard deviation? We contend that, due to the
dynamic nature of multi-allelic CNPs a standardized
number of technical replicates (for example 2–3), is in-
appropriate when the difference between copy number
integers is not static. Evidence to support this was
reported by Weaver et al. 2010 where using a standard
deviation of 0.16, and false positive and false negativerate of 2.5%, would theoretically require a minimum of
4 replicates to distinguish 1 copy from 2 copies, 6 replicates
to distinguish 2 copies from 3 copies, 11 replicates to
distinguish 3 copies from 4 copies and 17 replicates to
distinguish 4 copies from 5 copies [19]. We summarized
some of the larger studies which have utilized real-time
QPCR to analyze the CCL3L1 gene and the Beta defensins
for disease association, and find that in all but one case,
two technical replicates have been used to conduct the
association study (Table 3). In the study presented here we
also performed a duplicate testing approach to real-time
QPCR, so that our data could be compared to previous
work. However, under this model, it would appear that the
use of real-time QPCR is questionable for analyzing the
CCL3L1 gene which commonly varies between 0–4 copies
per diploid genome [5] and totally inappropriate for beta
defensins given the copy number range is much higher,
commonly between 2–7 copies [20].
Previous studies have highlighted the critical importance
of implementing copy number reference samples, plotting
the raw unrounded copy number measurement data and
observing the clustering around integer values in disease
association studies [2,5,25]. We also demonstrate that
assay validation should not consist solely in genotyping
positive controls as real-time QPCR performed com-
parably to PRT and MLPA when a small number of
positive controls were genotyped. Our data shows that
because the variance for real-time QPCR measurements
surrounding integer values is substantially greater than
that of the PRT or MLPA systems, only by plotting and
ordering the raw unrounded measurements from a larger
sample size on a histogram can the short-comings of
QPCR be identified. It is when a smaller sample size is
utilized that the results can potentially be misleading.
We would like to point out that this can be done by
genotyping as few as 40 test samples, well before an entire
cohort is genotyped. Therefore, we believe the use of posi-
tive controls should be strictly limited to assessing the
ability of an assay to detect copy number variation, and
then calibrating inter-run variation.
In some cases, studies using real-time QPCR have sys-
tematically removed uncertain data that fails to cluster
around integer values in an attempt to reduce the impact
of measurement error [26,27]. However, calling samples
with only a high degree of certainty may result in bias,
as the failure to cluster is unlikely to be independent of
genotype [28]. A more robust approach using real-time
QPCR would be to firstly; perform a sufficient number
of replicates as dictated by the copy number content of
the given region; secondly repeat samples in which the
inference of the most likely copy number has extended
error bars, utilize the z-scores to highlight data with
low confidence [29]; and thirdly, implement a statistical
model such as CNVtools which specifically controls for
Table 3 Reported number of technical replicates used in real-time QPCR studies for disease association
Studies Gene Disease association Technical replicates performed
Gonzalez et al. [1] CCL3L1 HIV related Outcomes 2
Urban et al. [9] CCL3L1 HIV related Outcomes 2
Bhattacharya et al. [8] CCL3L1 HIV related Outcomes 3
Field et al. [14] CCL3L1 T1 Diabetes 2
Mamtani et al. [21] CCL3L1 Systemic Lupus Erythematosus 2
Fellerman et al. [22] Beta-defensin Crohn’s Disease 3
Bentley et al. [23] Beta-defensin Crohn’s Disease 2
Mehlotra et al. [24] Beta-defensin HIV related Outcomes 2
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allowing one to input data as probability weighted CNV
scores as well as integers [28].
One of the more troubling aspects regarding the use
of real-time QPCR in our study is the failure to form
integer clusters on a sample set of high quality DNA of
similar concentration. This suggests that real-time QPCR
is inherently prone to measurement error. Moreover this
error may be exacerbated by varying sample quality in
large case/control cohorts potentially leading to false
positive associations. However, it is also noteworthy
that real-time QPCR is not substantially incorrect in its
assessment of copy number genotype, as demonstrated in
Table 2. Our data shows that even though under optimal
conditions the variance of real-time QPCR is considerable
across large sample numbers, however it still may have
a place as purely a confirmatory assay for sequencing
projects or MLPA and PRT data sets.
The consistent level of clustering observed by both the
PRT and MLPA systems performed without replicates or
repeat testing is unequivocal evidence of their accuracy
and reliability on a large scale. Additionally, we have not
fully utilized the multiplexing capacity of MLPA [11] or
Triplex PRT [5] which would further improve the copy
number typing of these systems. One important aspect
to consider is that combining measurements from two
independent techniques, such as PRT and MLPA, is very
powerful with respect to accuracy and reproducibility.
We found that MLPA and PRT calls differed by a single
copy in five samples, notably in the 4–5 copy range.
However, by combining the two techniques using a con-
cordance plot we were able to unambiguously assign
copy number to these samples (Figure 4A).
We argue that many multi-allelic CNP regions have
been largely underestimated with regard to the complexity
of analysis, as evidenced by the large number of contra-
dictory evidence concerning disease association studies
(reviewed in [7]). There also appears to be a fundamental
need to understand how these techniques work, along
with which variables can impact the reproducibility of the
assay. We also highlight that real-time QPCR appearsto be satisfactory for detecting differences between 1
and 2 copies, thus may be appropriate for the detection
of di-allelic CNPs where the differences between the
integers are at least 2-fold. Recently, water in oil digital
droplet PCR (ddPCR) has been described for genotyping
multi-allelic loci with an impressive level of reproducibility
and accuracy [30,31]. While this technology has not yet
been widely implemented for association studies, it is
likely that ddPCR will resolve a number of issues regard-
ing measurement error in large cohorts. The development
of a low cost genotyping assay that can provide accurate
copy number content, and also possesses the ability to
discriminate sequence content, including smaller insertion/
deletions and paralogue specific variation, is required
to fully understand the complex nature of multi-copy
genomic regions. Recent work combining molecular
inversion probes (MIPs) together with massively parallel
DNA sequencing [32] appears perfectly suited for this type
of analysis and will bridge the gap between locus specific
quantitative measures and whole genome sequencing
technologies. Although MIPs have immense promise for
accurately genotyping multi-allelic CNPs such as CCL3L1,
it is noteworthy that MIP technology is heavily reliant
on high quality reference sequences and availability of
singly unique nucleotides (SUNs) to accurately distinguish
gene family paralogs. Therefore at present MIP- based
genotyping cannot be universally applied to all multi-
allelic CNP regions.
Conclusions
In conclusion the data presented here clearly demonstrates
that real-time QPCR is prone to measurement error when
applied to genotyping the CCL3L1 multi-allelic CNP region.
We recommend that real-time QPCR data be treated with
a high degree of caution and suggest that if it is used for the
analysis of multi-allelic CNPs, that it is accompanied by
independent genotyping measures such as MLPA or PRT.
With reference to quantitative measures, ddPCR technol-
ogy, MIPs or MLPA and PRT, represent far more reliable
and robust approaches for accurately resolving multi-allelic
CNPs and should be used in preference if possible.
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